Virtu KCG Holdings’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Virtu KCG Holdings’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$177K	Sell	14,873 -25,685	-63%	-$319K	﹤0.01%	2218
2017 Q1	$599K	Buy	40,558 +23,105	+132%	+$374K	0.02%	1187
2016 Q4	$282K	Sell	17,453 -22,787	-57%	-$413K	0.01%	2178
2016 Q3	$730K	Buy	40,240 +8,875	+28%	+$173K	0.02%	999
2016 Q2	$517K	Buy	+31,365	New	+$507K	0.01%	1336
2015 Q4	–	Sell	-28,667	Closed	-$568K	–	4141
2015 Q3	$568K	Buy	28,667 +14,672	+105%	+$464K	0.01%	1394
2015 Q2	$486K	Buy	13,995 +3,398	+32%	+$104K	0.01%	1512
2015 Q1	$275K	Buy	+10,597	New	+$194K	0.01%	2012
2014 Q2	–	Sell	-17,964	Closed	-$271K	–	4224
2014 Q1	$271K	Buy	+17,964	New	+$203K	﹤0.01%	2625
2013 Q4	–	Sell	-21,947	Closed	-$74K	–	4421
2013 Q3	$74K	Buy	+21,947	New	+$57.9K	﹤0.01%	3435

Other funds holding HZNP

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Virtu KCG Holdings's HZNP Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 63% in Q2 2017, selling an estimated $319K and leaving 14,873 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #2218.

Virtu KCG Holdings first reported a position in HZNP in Q3 2013 and has held it in 10 quarters since. The position peaked at $730K in Q3 2016. 190 funds tracked by Wall St. Rank hold HZNP as of Q2 2017.

Virtu KCG Holdings held 14,873 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $177K as of Q2 2017.
Virtu KCG Holdings sold 25,685 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2017, an estimated $319K.
Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2218 holding.
Virtu KCG Holdings first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2013 and has held it in 10 quarters since.
Virtu KCG Holdings's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $730K in Q3 2016.
190 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.